Clean Science and Technology Limited’s wholly owned subsidiary, Clean-Fino Chem Limited, has entered into a definitive agreement for a long-term strategic collaboration with Geneus Chem AG, a company incorporated under the laws of Switzerland. The partnership aims to support the specialty chemicals portfolio of Clean Science and Technology Limited through the exclusive worldwide manufacture of advanced grades of HALS products. The manufacturing operations will be undertaken domestically, with products sold in both domestic and international markets.

The collaboration agreement was executed on July 16, 2026, between Clean-Fino Chem Limited, Geneus Chem AG, and the co-founders of the Swiss entity. The definitive agreements include provisions for minimum offtake commitments, a pricing mechanism, product specifications, and non-compete obligations. Lodha Capital Markets Ltd acted as the financial advisor, while AZB & Partners served as the legal advisor for the transaction.

In consideration for the manufacturing and supply agreement, Geneus Chem AG has agreed to issue share warrants to Clean-Fino Chem Limited. These warrants are exercisable within a period of four years from the date of issuance. Upon exercise, the subsidiary will acquire a 25% stake in the share capital of Geneus Chem AG on a fully diluted basis. No consideration is payable by the subsidiary for the subscription to these share warrants, though a nominal price per share will be required upon exercise.

Geneus Chem AG, incorporated in 2022, is currently a start-up not operating at a significant scale in terms of revenue. The company is engaged in the research, development, and trading of chemical products, with a specific focus on advanced grades of HALS Products. The transaction does not constitute a related party transaction, and no governmental or regulatory approvals are required for the acquisition.

The strategic move aligns with the company’s broader business strategy to enhance its offerings in the specialty chemicals sector. The consideration for manufacturing services will be determined based on a pricing formula agreed upon between the parties involved.

Key Details of the Collaboration

Clean Science & Technology disclosed an inter-se transfer of equity shares among members of its promoter group via gift. The transfer was executed without consideration and reported to the stock exchanges in compliance with Regulation 10(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The aggregate holding of the promoter and promoter group remains unchanged at 18.86% of the total share capital following the transaction.

The company submitted the report to BSE Limited and the National Stock Exchange of India Limited on June 26, 2026. The filing detailed the off-market transfer of shares among the promoter and promoter group, specifically under Regulation 10(1)(a)(ii) of the SEBI SAST Regulations. The disclosures were filed under Application Nos. 702, 701, and 683 respectively on the SEBI Intermediary Portal between June 22 and June 23, 2026. An applicable fee of Rs. 1,50,000 plus 18% GST was paid to SEBI on June 23, 2026.

Transfer Details

The transfer involved four distinct transactions, moving shares from individual promoters to business trusts within the group. The total shares transferred represent 18.86% of the proposed shareholding.

Regulatory Compliance

The acquirers, including ARB Business Trust, AAB Business Trust, and Smt. Alaknanda Boob Business Trust, submitted necessary disclosures to the Securities and Exchange Board of India (SEBI). Ruchita Vij, Company Secretary and Compliance Officer of Clean Science and Technology Limited, signed the submission to the exchanges.